Can Finasteride Be Added to Spironolactone in Women with Hirsutism?
Yes, finasteride can be added to spironolactone therapy in women with hirsutism, and this combination is more effective than spironolactone alone, reducing hirsutism scores by approximately 51% versus 37% with monotherapy. 1, 2
Evidence for Combination Therapy
The Endocrine Society Clinical Practice Guidelines explicitly acknowledge combination antiandrogen therapy for hirsutism. While their meta-analysis of antiandrogens combined with oral contraceptives showed no significant overall benefit, the guideline specifically notes that when spironolactone or finasteride were combined with OCPs, the results differed from other combinations 1. This suggests these particular agents may have additive effects.
Direct Comparison Data
The strongest evidence comes from a randomized controlled trial directly comparing combination therapy to monotherapy:
- Spironolactone 100 mg/day + Finasteride 5 mg/day: 51.3% reduction in hirsutism scores
- Spironolactone 100 mg/day alone: 36.6% reduction in hirsutism scores
- The difference was statistically significant (P<0.005) 2
Both regimens showed similar safety profiles with comparable side effects, making the combination well-tolerated 2.
Recommended Dosing
Based on guideline recommendations 1:
- Spironolactone: 100-200 mg/day (divided into twice-daily dosing)
- Finasteride: 2.5-5 mg/day
Critical Safety Considerations
Teratogenicity - Absolute Contraindication in Pregnancy
Both medications are absolutely contraindicated in pregnancy due to severe teratogenic effects, particularly feminization of male fetuses:
- Finasteride: Causes feminization of male fetuses through anti-androgenic effects on sex differentiation during embryogenesis 3
- Spironolactone: Animal studies show feminization of male fetuses at therapeutic doses, with persistent reproductive tract abnormalities 4
Effective contraception is mandatory - the Endocrine Society recommends against antiandrogen monotherapy unless adequate contraception is used (strong recommendation) 1. This applies even more critically to combination therapy.
Practical Implementation
- Verify negative pregnancy test before initiating therapy
- Ensure reliable contraception throughout treatment (oral contraceptives are often used concurrently, which also helps suppress ovarian androgens)
- Counsel extensively about teratogenic risks
- Consider adding an oral contraceptive to the regimen for both contraception and additional androgen suppression
Treatment Timeline
- Minimum trial period: 6 months before adjusting therapy 1
- Expected response: Gradual improvement over 6-12 months
- Long-term maintenance: May require ongoing therapy, as hirsutism often recurs after discontinuation
When to Consider Combination Therapy
Add finasteride to spironolactone when:
- Suboptimal response to spironolactone monotherapy after 6 months
- Moderate to severe hirsutism requiring more aggressive treatment
- Patient desires faster or more complete response
- Adequate contraception is ensured
Mechanism of Complementary Action
The combination works through different mechanisms:
- Spironolactone: Blocks androgen receptors competitively and reduces adrenal androgen production 5
- Finasteride: Inhibits type II 5α-reductase, preventing conversion of testosterone to the more potent dihydrotestosterone (DHT) 1
This dual mechanism explains the superior efficacy compared to monotherapy.
Alternative Considerations
If combination therapy is needed but finasteride is unavailable or contraindicated, other options include adding an oral contraceptive to spironolactone, though the guideline meta-analysis showed variable results with this approach 1.